Levels of Inflammatory Markers in the Treatment of Stroke ( LIMITS ) was an international , multicenter , prospective ancillary biomarker study nested within Secondary Prevention of Small Subcortical Strokes ( SPS@ ) , a phase III trial in patients with recent lacunar stroke .